Xyzal and Nalbuphine hydrochloride drug interactions - a phase IV clinical study of FDA data
Summary:
We study 21,720 people who take Xyzal (levocetirizine dihydrochloride) and Nalbuphine hydrochloride (nalbuphine hydrochloride). There is no drug interaction reported.
The study analyzes what interactions people have when they take Xyzal and Nalbuphine hydrochloride. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Xyzal?
Xyzal has active ingredients of levocetirizine dihydrochloride. It is often used in allergies. eHealthMe is studying from 21,479 Xyzal users. Check the latest studies of Xyzal.
What is Nalbuphine hydrochloride?
Nalbuphine hydrochloride has active ingredients of nalbuphine hydrochloride. eHealthMe is studying from 241 Nalbuphine hydrochloride users. Check the latest studies of Nalbuphine hydrochloride.
No report is found.
Do you take Xyzal and Nalbuphine hydrochloride?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Xyzal (21,479 reports)
- Nalbuphine hydrochloride (241 reports)
How the study uses the data?
The study uses data from the FDA. It is based on levocetirizine dihydrochloride and nalbuphine hydrochloride (the active ingredients of Xyzal and Nalbuphine hydrochloride, respectively), and Xyzal and Nalbuphine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Graft Versus Host Disease and Blood Albumin Decreased - a second ago
- Vicoprofen vs. Subutex, side effect and effectiveness comparison - 4 seconds ago
- Drug interactions of Temazepam and Tracleer - 7 seconds ago
- Drug interactions of Celexa and Tri-Sprintec - 10 seconds ago
- Drug interactions of Hydroxyzine Hydrochloride and Midazolam Hydrochloride - 11 seconds ago
- Benadryl vs. Zyrtec, side effect and effectiveness comparison - 12 seconds ago
- Drug interactions of Temazepam and Bupropion Hydrobromide - 14 seconds ago
- Drug interactions of Xpovio and Flonase Allergy Relief - 23 seconds ago
- Irritable Bowel Syndrome and Kidney Stones - 25 seconds ago
- Drug interactions of Claritin and Tenex - 32 seconds ago